Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction

CRISPR/Cas enhanced correction of the sickle cell disease (SCD) genetic defect in patient-specific induced Pluripotent Stem Cells (iPSCs) provides a potential gene therapy for this debilitating disease. An advantage of this approach is that corrected iPSCs that are free of off-target modifications c...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Ding, Lei, Sun, Chiao-Wang, Wu, Li-Chen, Zhou, Dewang, Pawlik, Kevin M., Khodadadi-Jamayran, Alireza, Westin, Erik, Goldman, Frederick D., Townes, Tim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961958/
https://www.ncbi.nlm.nih.gov/pubmed/27460639
http://dx.doi.org/10.1038/srep30422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961958/
https://www.ncbi.nlm.nih.gov/pubmed/27460639
http://dx.doi.org/10.1038/srep30422

Ejemplares similares